Rna Diagnostics, Inc. is developing a diagnostic test, named RDA (RNA Disruption Assay) which measures an individual patient’s tumor response to chemotherapy and accurately predicts whether the drug regimen will lead to elimination of the disease. In order to commercialize the intellectual property related to RDA, Rna Diagnostics, Inc. requires mathematical and statistical expertise to […]
Read More